Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling

PVRI Member Authors: Alexander Rothman, Peter Hickey, Nicholas Morrell, James West, Allan Lawrie


Bone morphogenetic protein receptor type 2 (BMPR2) mutations are present in patients with heritable and idiopathic pulmonary arterial hypertension (PAH). Circulating levels of interleukin-1 (IL-1) are raised in patients and animal models. Whether interplay between BMP and IL-1 signaling can explain the local manifestation of PAH in the lung remains unclear. Cell culture, siRNA, and mRNA microarray analysis of RNA isolated from human pulmonary artery (PASMC) and aortic (AoSMC) smooth muscle cells were used. R899X+/– BMPR2 transgenic mice fed a Western diet for six weeks were given daily injections of IL-1ß prior to assessment for PAH and tissue collection. PASMC have reduced inflammatory activation in response to IL-1ß compared with AoSMCs; however, PASMC with reduced BMPR2 demonstrated an exaggerated response. Mice treated with IL-1ß had higher white blood cell counts and significantly raised serum protein levels of IL-6 and osteoprotegerin (OPG) plasma levels recapitulating in vitro data. Phenotypically, IL-1ß treated mice demonstrated increased pulmonary vascular remodeling. IL-1ß induces an exaggerated pulmonary artery specific transcriptomic inflammatory response when BMPR2 signaling is reduced.

Read the full article online


Inflammatory and Immune Cells
Pulmonary Hypertension
Pulmonary Vascular Remodeling


Josephine Pickworth, James Iremonger, Helen Casbolt, Kay Hopkinson, Santhi Gladson, Sheila Shay, Sheila E. Francis

Published in:

Pulmonary Circulation Vol 7: No 4 cover image

December 2017

Pulmonary Circulation Vol 7: No 4

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI